NM18Contrast

#NephMadness 2018: To Screen or Not to Screen (For Renal Function) in the Era of Class II GBCAs

April 19, 2018 // 0 Comments

Editor’s Note: Unfortunately, we misfiled this commentary and discovered our mistake too late to post this during the peak of NephMadness. Our apologies to Dr Schieda. [...]

#NephMadness 2018: Weisbord’s Wisdom on Contrast

March 26, 2018 // 0 Comments

Steven Weisbord, MD Dr. Weisbord is a Staff Nephrologist in the VA Pittsburgh Healthcare System and Associate Professor of Medicine and Clinical and Translational Science at [...]

#NephMadness 2018: Gadolinium – Are We Overregulating or Overprescribing?

March 22, 2018 // 1 Comment

Saurabh Jha, MD Dr. Jha is Associate Professor of Radiology at the Hospital of the University of Pennsylvania. He is an argumentative radiologist and an opinionated blogger. [...]

#NephMadness 2018: Gadolinium Toxicity – Gaps in Knowledge

March 22, 2018 // 1 Comment

Brent Wagner, MD Dr. Wagner is the inaugural Director of the Kidney Institute of New Mexico, the Renal Section Chief of the New Mexico Veterans Administration Health Care [...]

#NephMadness 2018: Contrast Nephropathy is Back!

March 18, 2018 // 1 Comment

Amanda Leonberg-Yoo, MD Dr. Leonberg-Yoo is an Assistant Professor of Medicine at the Perelman School of Medicine of the University of Pennsylvania and a clinical [...]

#NephMadness 2018: Contrast Region

March 15, 2018 // 5 Comments

Submit your picks! | NephMadness 2018 | #NephMadness | #ContrastRegion Selection Committee Member for the Contrast Region: Paul M. Palevsky, MD Dr. Palevsky is a [...]